Impact of sacubitril/valsartan on atrial fibrillation burden in heart failure: a retrospective observational study.
Background: Sacubitril/valsartan (an angiotensin receptor‐neprilysin inhibitors [ARNI]) might improve atrial fibrillation (AF) condition, but its added value remains controversial. Aim: We aimed to analyse the effect of ARNI on AF burden. Method: We conducted a single‐centre, retrospective self‐cont...
| Publicado en: | Journal of Pharmacy Practice & Research Vol. 55; no. 1; pp. 53 - 61 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Feb2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |